Gilead Sciences, Inc. (GILD) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 152.69B |
| Enterprise Value | 170.06B |
| P/E Ratio | -59.07 |
| PEG Ratio | 0.39 |
| Price/Sales Ratio | 6.25 |
| Price/Book Ratio | 16.14 |
| Enterprise/Revenue | 7.01 |
| Enterprise/EBITDA | 160.04 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -0.11 |
| Operating Margin | -0.05 |
AD
Management Effectiveness
| Return On Assets | -0.07 |
| Return On Equity | -0.16 |
Income Statement
| Revenue | 29.44B |
| Revenue/Share | 24.5 |
| Gross Profit | 23.21B |
| EBITDA | 13.58B |
| Net Income | 8.51B |
| Diluted EPS | 6.78 |
Balance Sheet
| Total Cash | 3.18B |
| Total Cash/Share | 2.56 |
| Total Debt | 26.25B |
| Total Debt/Equity | 2.22 |
| Current Ratio | 1.27 |
| Book Value Per Share | 9.45 |
Price History
| 52-Week Change | 23.77 |
| 52-Week High | 160.51 |
| 52-Week Low | 114.02 |
| Moving Average 50 Days | 147.7 |
| Moving Average 200 Days | 138.35 |
Statistics
| Average Volume | 6.04M |
| Shares Outstanding | 1.24B |
| % Held by Institutions | 90.19 |
Dividend And Splits
| Trailing Annual Dividend Rate | 3.25 |
| Trailing Annual Dividend Yield | 2.12 |
| Payout Ratio | -1.26 |
| Last Split Factor | 2:1 |
| Last Split Date | January 28, 2013 |
AD
